RegWardenFDA facility compliance records
Facility

HYCOR BIOMEDICAL

3 recall(s) on record — most severe on record: Class II.

Activity by year

FDA actions on record by year2018: 3 recalls; 2019: 1 inspections; 2025: 1 inspections2017320181201920202021202220232024120252026
  • Recalls (3)
  • Inspections (2)

Devices registered here (1)

  • System, Test, Radioallergosorbent (Rast) Immunological
    Product code DHB (opens in a new tab) · Class II · Immunology · 21 CFR 866.5750

Recalls & enforcement

  • Class IIOngoing2018-07-25
    Some of the Stop Solution bottles, a caustic solution, have been reported to leak.
  • Class IIOngoing2018-03-19
    Reports when using Rheumatoid Factor test kits, control and negative samples may be elevated following a sample containing high levels of IgG . The negative control may report out of range; a negative sample may recover as a low positive which could contribute to an incorrect o…
  • Class IICompleted2018-02-21
    Reports of higher than anticipated positivity rate for patients tested using IgM Kit. Some negative samples may be reported as positive for IgM antibodies to Rheumatoid Factor.

FDA inspections (2)

  • NAI2025-11-26
    No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices · citations posted
  • NAI2019-05-15
    No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices

Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “HYCOR BIOMEDICAL (FEI 1000125787) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/1000125787-hycor-biomedical/

Not open yet

Alerts for HYCOR BIOMEDICAL

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.